C R Bard Inc (BCR.N)
115.67USD
1 Aug 2013
$1.07 (+0.93%)
$114.60
$114.63
$115.95
$114.63
116,904
143,218
$115.95
$94.11
About
Overall
| Beta: | 0.39 |
| Market Cap (Mil.): | $9,070.99 |
| Shares Outstanding (Mil.): | 79.15 |
| Dividend: | 0.21 |
| Yield (%): | 0.73 |
Financials
| BCR.N | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 54.46 | 27.50 | 37.76 |
| EPS (TTM): | 2.10 | -- | -- |
| ROI: | 5.40 | 9.26 | 18.76 |
| ROE: | 10.44 | 12.54 | 19.59 |
Deals of the day -- mergers and acquisitions
June 28 - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Friday:
Boston Sci to buy Bard electrophysiology unit for $275 mln
WASHINGTON, June 28 - Medical device maker Boston Scientific Corp said on Friday it would buy the electrophysiology (EP) business of C.R. Bard Inc for $275 million in cash, expanding its roster of products that help treat patients with an abnormal heartbeat.
C R Bard to pay $48 million to settle kickback allegations, DOJ says
- Medical device maker C.R. Bard Inc will pay about $48.3 million to resolve allegations it made illegal payments to hospitals and physicians to entice them to buy its radiation treatment for prostate cancer, the Justice Department said.
C R Bard to pay $48 mln to settle kickback allegations, DOJ says
May 13 - Medical device maker C.R. Bard Inc will pay about $48.3 million to resolve allegations it made illegal payments to hospitals and physicians to entice them to buy its radiation treatment for prostate cancer, the Justice Department said.
Competitors
| Price | Change | |
|---|---|---|
| Covidien plc (COV.N) | $62.93 | +1.30 |
| Boston Scientific Corporation (BSX.N) | $11.15 | +0.23 |
| St. Jude Medical, Inc. (STJ.N) | $53.00 | +0.61 |
| Abbott Laboratories (ABT.N) | $36.84 | +0.21 |
| Teleflex Incorporated (TFX.N) | $79.28 | -0.15 |
| AngioDynamics, Inc. (ANGO.OQ) | $12.13 | +0.18 |
| Becton, Dickinson and Co. (BDX.N) | $103.11 | -0.61 |
| Johnson & Johnson (JNJ.N) | $93.77 | +0.27 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Trading Report for (BCR). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
|
Provider: MacroRisk Analytics/EconomicInvestor
|
$15.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

